Doximity, Inc. (DOCS)
NYSE • Healthcare
Last close at October 8, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Doximity, Inc. keeps $16 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 5
in 27 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Doximity missed on adjusted EPS but beat revenue in the first fiscal quarter of 2027, based on preliminary results reported Aug. 6. Revenue rose about 7% to roughly $156.6 million from $145.9 million a year ago, topping the about $151.8 million consensus by about 3%. Adjusted EPS of $0.29 missed the $0.30 estimate by about 4% and was down about 19% from $0.36 a year ago, while net income fell about 54% to roughly $24.3 million from $53.3 million. Gross profit came to about $132.9 million, with gross margin near 85%, and operating income was roughly $33.6 million as operating margin held around 22%. Operating cash flow was about $42.0 million, and the company repurchased roughly $91.6 million of stock. For the next period, consensus calls for EPS of $0.36 on revenue of $171.8 million.
Next report — what to expect
Doximity, Inc. (DOCS) reports on November 5, 2026. Wall Street is looking for consensus EPS of $0.349 on consensus revenue of $170.8 million. For trailing context, revenue grew +7.3% year over year last quarter. DOCS has beaten EPS in 6 of 8 most recent quarters.
About Doximity, Inc.
Doximity, Inc. operates a digital platform for healthcare practitioners and sells software and related services within healthcare information services. The company, listed on the NYSE as DOCS, generated $644.9 million in FY2026 revenue, with its business centered on the United States healthcare market and customers that include pharmaceutical companies and healthcare organizations.
Today's Snapshot
So far today, DOCS is trading 1.6% higher at 29.84, in line with a firmer sector. SBS Law, a law firm, invited investors to lead a securities-fraud lawsuit against Doximity.
Trading Volume
Below 10d avg (3.2M)
1.5M
vs S&P 500 Today
Outperforming Market
+1.06%
Updated: October 9, 2026 at 16:50 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$25.77 - $30.92Buy
- RSI (14)66.45Neutral
- Stochastic %K (14, 3, 3)85.84Sell
- MACD Level (12, 26)0.94Buy
Peers & Related Assets
Get premium market insights delivered directly to your inbox.